key: cord-0772419-65nroic5
authors: Yang, Qi; Liu, Qiang; Xu, Haibo; Lu, Hong; Liu, Shiyuan; Li, Hongjun
title: Imaging of Coronavirus Disease 2019: A Chinese Expert Consensus Statement
date: 2020-04-18
journal: Eur J Radiol
DOI: 10.1016/j.ejrad.2020.109008
sha: 980b28336e9800873445cfdf40e3f9b17ca81826
doc_id: 772419
cord_uid: 65nroic5

Abstract Coronavirus disease 2019 (COVID-19) is highly contagious, mainly causing inflammatory lesions in the lungs, and can also cause damage to the intestine and liver. The rapid spread of the virus that causes coronavirus disease 2019 (COVID-19) pneumonia has posed complex challenges to global public health. Early detection, isolation, diagnosis, and treatment are the most effective means of prevention and control. At present, the epidemic situation of new coronavirus infection has tended to be controlled in China, and it is still in a period of rapid rise in much of the world. The current gold standard for the diagnosis of COVID-19 is the detection of coronavirus nucleic acids, but imaging has an important role in the detection of lung lesions, stratification, evaluation of treatment strategies, and differentiation of mixed infections. This Chinese expert consensus statement summarizes the imaging features of COVID-19 pneumonia and may help radiologists across the world to understand this disease better.

A series of cases of pneumonia of unknown cause was reported in Wuhan, in late December 2019 [1] . Epidemiological data demonstrated person-to-person spread is the main mode of transmission, which resulted in a worldwide outbreak [2, 3] . World Health Organization (WHO) designated COVID-19 as the official name [4, 5] . The pathogen was confirmed to be severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a betacoronavirus [5] . Standard technique to confirm COVID-19 is nucleic acid testing with reverse transcription polymerase chain reaction (RT-PCR) and/or next-gen sequencing (NGS) methods [6, 7] . Imaging features differ in different individuals and stages of the COVID-19 pneumonia, and they are also different from other infectious pulmonary diseases [8] . In order to improve the diagnosis and treatment, we first drew up the "Guideline for medical imaging in auxiliary diagnosis of coronavirus disease 2019"and participant in "Radiological diagnosis of new coronavirus infected pneumonitis: Expert recommendation from the Chinese Society of Radiology (First edition)" [9] [10] .Based on these previous advices, this current overview and consensus statement is meant to inform radiologists in the rest of the world based on the Chinese experience.

In post-mortem cases, the lungs show consolidation in different degrees. Serum, fibrinous exudate, and transparent membrane formation are seen in the alveolar cavity; exudation cells are mainly monocytes and macrophages, and multinucleated giant cells are easily seen. Type 2 alveolar epithelial cells proliferated significantly, and some of the cells shed. Inclusion bodies can be seen in type 2 alveolar epithelial cells and macrophages. Alveolar septal vascular congestion and edema, monocyte and lymphocyte infiltration, and intravascular thrombosis can be seen. Focal hemorrhage and necrosis of lung tissue may occur with hemorrhagic infarction. Intra-alveolar fibrosis, resulting from organization of inflammatory exudates also can be found. The epithelium of the bronchial mucosa in lungs discards, and there is formation of mucus and mucus plugs in the cavity. Coronavirus particles can be seen in the bronchial mucosal epithelium and type 2 alveolar epithelial cells under an electron microscope [11] [12] .

J o u r n a l P r e -p r o o f

The incubation period is 1~14 days, mostly 3-7 days, based on the current epidemiological evidence [13] . Fatigue, and dry cough are the most common clinical onset symptoms. Nasal congestion, sore throat, and diarrhea are atypical clinical presentations [13] . Patients with mild or moderate type only demonstrate a low fever and mild fatigue without pneumonia in the early stage of the disease [13, 14] . Most patients have a good prognosis, with few patients becoming critically ill.

Prognosis is poor for the elderly and those with chronic underlying diseases, and the symptoms of children tend to be relatively mild [15, 16] . Some critically patients may have elevation of troponin level, and an increase of C-reactive protein can be seen. Critically ill patients may develop acute respiratory distress syndrome, septic shock with metabolic acidosis and coagulation dysfunction that are difficult to correct [16, 17] . For the clinical criteria, the first step is to ascertain the epidemiology history of suspected cases. Confirmed cases must be tested positive by RT-CPR assay or by NGS [18] .

SARS-CoV-2 nucleic acids can be detected in nasopharyngeal swabs, sputum, or other lower respiratory tract secretions, blood, and stools [19] .

There are four clinical types according to Chinese guideline on COVID-19 pneumonia [14] Mild Type: Clinical symptoms are mild and no signs of pneumonia are seen on imaging. 

In Western countries, CT is not considered a screening examination for COVID-19 [20 -22] . Due to various factors such as specimen collection technology, kit quality, and the diversity of disease evolution, the false-negative rate of nucleic acid detection is relatively high in China. In the situation of suspected crowds and limited medical resources, nucleic acid test negative but CT positive (highly suggestive of viral pneumonia) are also listed as medical isolation treatment criteria in China, which is more in line with the actual situation in Wuhan [18, 9] . Thus, infection prevention and control is a new task and a serious challenge facing the radiology department in China. All 

Imaging, in particular chest X-ray and computed tomography (CT), is important in the detection of lung lesions, assessment of lesion size, density, and evolution. Chest X-ray examination is convenient and fast, and has been proven effective in diagnosing other coronaviruses, such as severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) [23] [24] [25] [26] . However, the sensitivity and specificity for mild type patients are relatively low [27] . It is not recommended for patients with early COVID-19 stage. Chest CT scans can demonstrate almost all abnormalities including early mild exudative lesions. Chest CT is the most valuable imaging tool for the clinical diagnosis of early stage COVID-19 pneumonia when patients' symptoms are aspecific, especially in Wuhan with insufficient PCR tests in the early pandemic period [28, 29] . It is recommended to use volume CT with a maximum acquisition slice thickness of 5 mm (≥16 slice multi-detector CT) and a reconstruction slice thickness of 1.0 to 1.5 mm [30] . Multi-planar reformats (transverse, sagittal, J o u r n a l P r e -p r o o f and coronal planes) are beneficial for the early detection of lesions in patients with negative nucleic acid tests [9] .

Multiple small patchy shadows and interstitial changes in the lower zone of lungs are typical imaging features in common type patients [9] . With the progression of the disease, it may manifest as a patchy distribution or multiple consolidations [13, 27, 31] . In severe and critical type COVID-19 pneumonia, multifocal or diffuse consolidation can be seen in both lungs, showing as "white lung" [16] . Chest X-ray is only suitable for primary hospitals without examination conditions and follow-up of critically ill patients.

Typical features on chest CT include ground-glass opacity with a cloud-like change on chest CT, not obscuring the accompanying pulmonary vascular structures in lungs [32, 33] . Corresponding pathological changes are exudation in the alveolar cavity with partial filling of the air cavity, mainly from serous and fibrinous exudates, alveolar septal vascular congestion and edema. Disease progression mostly occurs in a course of 7-10 days, with enlarged and increased density of GGO, and consolidated lesions with air bronchogram sign [9, 34, 35] . GGOs from the early stage expand, and the density increases gradually. Consolidation shows increased lung parenchymal density, and blurred borders of the pulmonary blood vessels and airway walls due to the loss of air contrast. The lesion range can be acinar, leaflet, lung segment or lung lobe. Lesions are distributed as bilateral asymmetrical subpleural wedge-shaped or fan-shaped, mostly in the caudal regions of the lung and dorsal subpleural area [36] . When interlobular septa and intralobular interstitium are thickened, this is displayed as subpleural reticulation according to a "crazy paving" pattern [38] [39] [40] . The underlying pathological changes are pulmonary edema, protein exudation, thickening of intralobular interstitial, and multinucleated giant cells and macrophage infiltration in the alveolar cavity [37] . Critical stage disease may show further expansion of consolidations, with the whole lung showing increased opacity, a socalled "white lung" [9, 35] . In recovery stage patients, the lesion area is reduced and absorbed, or only residual fibrous lesions are seen [38] . Less common findings include pleural effusion, stretch bronchiectasis, and thoracic lymphadenopathy (Imaging examples are shown in Figures 1-5 ).

Chest CT can also evaluate the time course of COVID-19 and assess the evolution of disease severity. Chung et al [34] evaluated each of the five lung lobes and determined the degree of involvement and rated the severity of each lobe. The patients who had the highest score (of 19) were admitted to the intensive care unit with multiple bilateral GGOs and subsegmental consolidation. Pan et al [28] investigated the time course of lung changes during recovery from COVID-19 pneumonia. The results showed that with the evolution of the disease, GGO would enlarge with a crazy paving pattern and partial consolidation. Lung involvement reached a maximum at about the 10th day after the onset, and the crazy-paving pattern was resolved entirely in the absorption stage about the 14th day after the disease onset, which means that the crazypaving pattern may become an important indicator for evaluation of disease evolution. Other studies focusing on the evolution of COVID-19 pneumonia concluded that the lung segments showed marked changes with decreasing of GGOs and increasing of crazy-paving pattern and consolidation [9, [39] [40] [41] [42] . Patients recovering from COVID-19 can be tracked with CT to assess for long-term or permanent lung damage, including fibrosis. (Imaging examples are shown in Figures   6-7) .

Although the imaging features of COVID-19 overlap with those of SARS and MERS, there are differences on imaging exams that set the COVID-19 pneumonia apart. It is essential to make a differential diagnosis for early identification of borderline patients and determination of the appropriate treatment. Viral pneumonia is characterized by alveolar wall edema and interstitial changes [43] . Streptococcus pneumonia is characterized by the consolidation of lobes or lobules without GGO [44] . Both mycoplasma and aspiration pneumonia distribute along the bronchovascular bundle [45] [46] [47] , which is significantly different from COVID-19 pneumonia. In a study comparing chest CT from 219 patients with COVID-19 pneumonia in China and 205 patients with other causes of viral pneumonia in the United States, COVID-19 pneumonia cases were more likely to have a peripheral distribution (80 versus 57 percent), and GGO (91 versus 68 percent) [8] .

COVID-19 patients more frequently had multifocal involvement on CT, compared with unifocal J o u r n a l P r e -p r o o f involvement in SARS and MERS [24, 26, 48] . Table 1 shows the differential diagnosis between COVID-19 pneumonia and other respiratory disease.

A large amount of CT images makes it difficult for radiologists to compare among serial studies.

Thus, rapid detection, accurate location of lesions, and evaluation of lesion size, properties, and lesion dynamics are urgent issues that need to be addressed. An AI-assisted diagnostic system for COVID-19 has been developed in China. It takes about 15 seconds with an accuracy rate above 90% [49] . The AI-system has outstanding performance in the detection of subtle GGO, which is the most easily missed typical CT feature of COVID-19. Also, it can precisely segment the lesion region, calculate the lesion volume, volume rates of lesions to total/left/right lung, and each lung lobe. Comparing CT scans of the same patient at several time points, the radiologist can use the system to measure changes in each lesion and track the progression of the disease (Figure 8 ). Some researchers have tried to apply AI in CT image analysis to differentiate COVID-19 from other viral pneumonia patients [50] . With clinical symptoms, laboratory testing results, and contact or travel history, the AI system can help doctors identify patients with risk of progressing to a more severe disease state at the time of admission, for timely, precise, and effective treatment decisions. Hence, precise lesion labeling, segmentation, and quantification analysis of COVID-19 lesions is the future of AI.

In general, combined chest CT, clinical symptoms, and laboratory tests facilitates the diagnosis of COVID-19. Increasing in-depth understanding of the disease, research, and the continuous improvement of AI technology will further promote the establishment of a comprehensive prevention and control system of early screening, diagnosis, isolation, and treatment of COVID-19 pneumonia.

The authors declare that they have no competing interests. 

Multifocal GGO associated with air bronchogram and/or crazypaving pattern

The lesions can be segmental or lobular distribution, partially confluent

Wedge-shaped or fanlike perpendicular to the bronchovascular bundle

Clinical management of severe acute respiratory infection when novel coronavirus (nCoV)

Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany

Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia

Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus

Coronaviridae Study Group of the International Committee on Taxonomy of, The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Nucleic Acid Amplification Tests for the Diagnosis of Pneumonia

Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT, Radiology

Chinese Society of Radiology. Radiological diagnosis of new coronavirus infected pneumonitis: Expert recommendation from the Chinese Society of Radiology

Guideline for medical imaging in auxiliary diagnosis of coronavirus disease 2019

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

Comparison of clinical and pathological features between severe acute respiratory syndrome and coronavirus disease

Clinical Characteristics of Coronavirus

Radiology Department Preparedness for COVID-19: Radiology Scientific Expert Panel, Radiology

Radiological Society of North America Expert Consensus Statement on Reporting Chest CT Findings Related to COVID-19. Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA

Thoracic Imaging in COVID-19 Infection: Guidance for the Reporting Radiologist

Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore

Chest radiographic findings of a case of severe acute respiratory syndrome (SARS) in Singapore

Severe acute respiratory syndrome (SARS) in a paediatric cluster in Singapore

Early identification of pneumonia patients at increased risk of Middle East respiratory syndrome coronavirus infection in Saudi Arabia

Clinical Characteristics of Coronavirus Disease 2019 in China

Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China

Clinical and High-Resolution CT Features of the COVID-19 Infection: Comparison of the Initial and Follow-up Changes

Expert Consensus on Imaging Diagnosis and Infection Control for COVID-19

Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series

Thin-Section CT of the Secondary Pulmonary Lobule: Anatomy and the Image-The 2004 Fleischner Lecture

Radiographic and CT Features of Viral Pneumonia

CT Imaging Features of

Chest imaging appearance of COVID-19 infection

CT Imaging of the 2019 Novel Coronavirus

Imaging of pulmonary viral pneumonia

Novel Coronavirus (2019-nCoV) Pneumonia

Chest Radiographic and CT Findings of the 2019 Novel Coronavirus Disease (COVID-19): Analysis of Nine Patients Treated in Korea

Evolution of CT Manifestations in a Patient

Novel Coronavirus (2019-nCoV) Pneumonia in Wuhan, China

Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia

Imaging profile of the COVID-19 infection: radiologic findings and literature review

Radiologic Pattern of Disease in Patients with Severe Acute Respiratory Syndrome: The Toronto Experience

Thin-section CT findings of patients with acute Streptococcus pneumoniae pneumonia with and without concurrent infection

Mycoplasma pneumonia: Clinical features and management

Differentiation between mycoplasma and viral community-acquired pneumonia in children with lobe or multi foci infiltration: a retrospective case study

Squalene Aspiration Pneumonia: Thin-Section CT and Histopathologic Findings

Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection: Chest CT Findings

China uses AI in medical imaging to speed up COVID-19 diagnosis

Artificial intelligence applications for thoracic imaging